CDNA
insider transactionsCareDx, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-114.2K
0 buy · 114.2K sell
Net value · 365d
-$2.6M
$0 in · $2.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
12
0 buy · 114.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director · 10b5-1
$279.7K
12.1K sh · $23.11
Own -25%
-
Sell·S
President and CEO · 10b5-1
$424.9K
17.7K sh · $24.03
Own -3%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +36%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +25%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +33%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +5%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +6%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +20%
-
Grant·A
Director · 10b5-1
$0
9.8K sh
Own +7%
-
Sell·S
President and CEO · 10b5-1
$528.4K
22.0K sh · $24.02
Own -3%
-
Other·F
Secretary and General Counsel
$28.4K
1.3K sh · $21.95
Own -1%
-
Sell·S
President and CEO · 10b5-1
$116.0K
4.8K sh · $24.00
Own -1%
-
Sell·S
Director
$129.0K
6.5K sh · $19.89
Own -14%
-
Sell·S
Director
$85.7K
4.1K sh · $20.97
Own -8%
-
Sell·S
Secretary and General Counsel
$55.6K
2.7K sh · $20.68
Own -2%
-
Other·F
Secretary and General Counsel
$61.8K
2.9K sh · $21.50
Own -2%
-
Grant·A
Keith Kennedy KEY
CFO & COO
$0
24.1K sh
Own +12%
-
Sell·S
President and CEO · 10b5-1
$217.2K
10.3K sh · $21.12
Own -1%
-
Other·F
President and CEO
$1.1M
62.0K sh · $17.57
Own -8%
-
Other·F
Secretary and General Counsel
$33.7K
1.9K sh · $17.82
Own -2%
-
Grant·A
Director
$0
2.0K sh
Own +1%
-
Grant·A
Director
$0
0 sh
Own +0%
-
Grant·A
Director
$25.0K
2.3K sh · $10.90
Own +12%
-
Other·F
Chief Commercial Officer
$132.0K
7.4K sh · $17.87
Own -4%
-
Other·F
Secretary and General Counsel
$71.2K
4.0K sh · $17.87
Own -3%
-
Other·F
President and CEO
$626.1K
35.0K sh · $17.87
Own -4%
-
Other·F
Keith Kennedy KEY
CFO & COO
$209.5K
11.7K sh · $17.87
Own -6%
-
Exercise·M
Director
$0
11.5K sh
Own New
-
Exercise·M
Director
$0
9.7K sh
Own New
-
Exercise·M
Director
$0
5.3K sh
Own New
-
Exercise·M
Director
$14.0K
11.5K sh · $1.22
Own +7%
-
Exercise·M
Director
$48.2K
9.7K sh · $4.95
Own +6%
-
Exercise·M
Director
$26.4K
5.3K sh · $5.02
Own +3%
-
Sell·S
Secretary and General Counsel
$91.3K
4.4K sh · $20.56
Own -3%
-
Other·F
Nathan Smith KEY
Chief Financial Officer
$78.8K
3.9K sh · $20.42
Own -5%
-
Grant·A
Nathan Smith KEY
Chief Financial Officer
$0
7.9K sh
Own +10%
-
Grant·A
Nathan Smith KEY
Chief Financial Officer
$0
33.0K sh
Own +79%
-
Other·F
Chief Commercial Officer
$90.5K
4.4K sh · $20.42
Own -2%
-
Grant·A
Chief Commercial Officer
$0
11.6K sh
Own +7%
-
Grant·A
Chief Commercial Officer
$0
60.0K sh
Own +55%
-
Other·F
Secretary and General Counsel
$60.6K
3.0K sh · $20.42
Own -2%
-
Other·F
Secretary and General Counsel
$50.9K
2.5K sh · $20.42
Own -2%
-
Grant·A
Secretary and General Counsel
$0
4.3K sh
Own +3%
-
Grant·A
Secretary and General Counsel
$0
33.0K sh
Own +34%
-
Other·F
President and CEO
$279.6K
13.7K sh · $20.42
Own -2%
-
Grant·A
President and CEO
$0
37.6K sh
Own +5%
-
Grant·A
President and CEO
$0
162.5K sh
Own +27%
-
Other·F
Chief Operating Officer
$94.8K
4.6K sh · $20.42
Own -2%
-
Grant·A
Chief Operating Officer
$0
14.5K sh
Own +7%
-
Grant·A
Chief Operating Officer
$0
60.0K sh
Own +43%
-
Sell·S
President and CEO · 10b5-1
$408.0K
19.3K sh · $21.16
Own -3%
-
Sell·S
President and CEO · 10b5-1
$4.2K
200 sh · $21.00
Own -0%
-
Sell·S
President and CEO · 10b5-1
$213.8K
10.2K sh · $21.05
Own -2%
-
Grant·A
Director
$0
1.5K sh
Own +1%
-
Grant·A
Director
$0
0 sh
Own +0%
-
Grant·A
Director
$25.0K
1.9K sh · $13.19
Own +11%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Hannah Valantine 10b5-1 | Sell S | 12.1K | $279.7K |
| Jun 15, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 17.7K | $424.9K |
| Jun 12, 2026 | Suresh Gunasekaran 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | Hannah Valantine 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | Richard Bryan Riggsbee 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | Michael Goldberg 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | Fred E Cohen 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | Christine Cournoyer 10b5-1 | Grant A | 9.8K | $0 |
| Jun 12, 2026 | George Bickerstaff 10b5-1 | Grant A | 9.8K | $0 |
| Jun 11, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 22.0K | $528.4K |
| Jun 6, 2026 | Jeffrey Adam Novack | Other F | 1.3K | $28.4K |
| Jun 4, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 4.8K | $116.0K |
| May 15, 2026 | Arthur A Torres | Sell S | 6.5K | $129.0K |
| May 14, 2026 | Arthur A Torres | Sell S | 4.1K | $85.7K |
| May 5, 2026 | Jeffrey Adam Novack | Sell S | 2.7K | $55.6K |
| May 1, 2026 | Jeffrey Adam Novack | Other F | 2.9K | $61.8K |
| Apr 20, 2026 | Keith Kennedy KEY | Grant A | 24.1K | $0 |
| Apr 16, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 10.3K | $217.2K |
| Apr 15, 2026 | John Walter Hanna JR KEY | Other F | 62.0K | $1.1M |
| Apr 6, 2026 | Jeffrey Adam Novack | Other F | 1.9K | $33.7K |
| Apr 2, 2026 | Michael Goldberg | Grant A | 2.0K | $0 |
| Apr 1, 2026 | Christine Cournoyer | Grant A | 0 | $0 |
| Apr 1, 2026 | Christine Cournoyer | Grant A | 2.3K | $25.0K |
| Apr 1, 2026 | Jessica Meng | Other F | 7.4K | $132.0K |
| Apr 1, 2026 | Jeffrey Adam Novack | Other F | 4.0K | $71.2K |
| Apr 1, 2026 | John Walter Hanna JR KEY | Other F | 35.0K | $626.1K |
| Apr 1, 2026 | Keith Kennedy KEY | Other F | 11.7K | $209.5K |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 11.5K | $0 |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 9.7K | $0 |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 5.3K | $0 |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 11.5K | $14.0K |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 9.7K | $48.2K |
| Mar 31, 2026 | Michael Goldberg | Exercise M | 5.3K | $26.4K |
| Feb 3, 2026 | Jeffrey Adam Novack | Sell S | 4.4K | $91.3K |
| Feb 2, 2026 | Nathan Smith KEY | Other F | 3.9K | $78.8K |
| Feb 2, 2026 | Nathan Smith KEY | Grant A | 7.9K | $0 |
| Feb 2, 2026 | Nathan Smith KEY | Grant A | 33.0K | $0 |
| Feb 2, 2026 | Jessica Meng | Other F | 4.4K | $90.5K |
| Feb 2, 2026 | Jessica Meng | Grant A | 11.6K | $0 |
| Feb 2, 2026 | Jessica Meng | Grant A | 60.0K | $0 |
| Feb 2, 2026 | Jeffrey Adam Novack | Other F | 3.0K | $60.6K |
| Feb 2, 2026 | Jeffrey Adam Novack | Other F | 2.5K | $50.9K |
| Feb 2, 2026 | Jeffrey Adam Novack | Grant A | 4.3K | $0 |
| Feb 2, 2026 | Jeffrey Adam Novack | Grant A | 33.0K | $0 |
| Feb 2, 2026 | John Walter Hanna JR KEY | Other F | 13.7K | $279.6K |
| Feb 2, 2026 | John Walter Hanna JR KEY | Grant A | 37.6K | $0 |
| Feb 2, 2026 | John Walter Hanna JR KEY | Grant A | 162.5K | $0 |
| Feb 2, 2026 | Keith Kennedy | Other F | 4.6K | $94.8K |
| Feb 2, 2026 | Keith Kennedy | Grant A | 14.5K | $0 |
| Feb 2, 2026 | Keith Kennedy | Grant A | 60.0K | $0 |
| Jan 22, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 19.3K | $408.0K |
| Jan 21, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 200 | $4.2K |
| Jan 15, 2026 | John Walter Hanna JR KEY 10b5-1 | Sell S | 10.2K | $213.8K |
| Jan 6, 2026 | Michael Goldberg | Grant A | 1.5K | $0 |
| Jan 2, 2026 | Christine Cournoyer | Grant A | 0 | $0 |
| Jan 2, 2026 | Christine Cournoyer | Grant A | 1.9K | $25.0K |
About CDNA insider trading
This page tracks insider transactions for CareDx, Inc. (CDNA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.